Hydroxychloroquine sulfate（King Hussein Cancer Center）

N/A

Report date: 2024/11/26 20:00:06

Base Information

Drug NameHydroxychloroquine sulfate（King Hussein Cancer Center）
Drug Alias NameHCQ-01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJordan
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKing Hussein Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKing Hussein Cancer Center
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A
Related LinksN/A